Optimal therapeutic range for oral anticoagulants in Japanese patients with prosthetic heart valves: A preliminary report from a single institution using conversion from thrombotest to PT-INR

Heart and Vessels

Volumn 15, Issue 3, 2000, Pages 124-128

  Uetsuka, Y ^a   Hosoda, S ^b   Kasanuki, H ^a   Aosaki, M ^c   Murasaki, K ^a   Ooki, K ^a   Inoue, M ^a   Akiyama, E ^a   Kitada, M ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Sakakibara Memorial Hospital   (Japan)

^c Yokohama National University   (Japan)

Author keywords

International normalized ratio; Mechanical valve; Oral anticoagulant therapy; Prothrombin time; Thrombotest; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE; TICLOPIDINE; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG MONITORING; FEMALE; FOLLOW UP; HEART VALVE PROSTHESIS; HEMATOLOGY; HEMOSTASIS; HUMAN; INCIDENCE; JAPAN; LINEAR SYSTEM; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; PROTHROMBIN TIME; REGRESSION ANALYSIS; STANDARD; STANDARDIZATION; TECHNIQUE; THROMBOEMBOLISM; THROMBOSIS; THROMBOTEST;

EID: 0034458633     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007265     Document Type: Article

References (12)

1. The laboratory control of anticoagulant therapy in large groups of patients
2. International Committee for Standardization in Haematology/International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulation control
3. Thrombotest. A new method for controlling anticoagulant therapy
4. Therapeutic range for oral anticoagulant therapy
5. The optimal intensity of oral anticoagulant therapy
6. Therapeutic target values in oral anticoagulation - Justification of Dutch policy and a warning against the so-called moderate-intensity regimens
7. Guidelines on oral anticoagulation; second edition
8. Oral anticoagulants; mechanisms of action, clinical effectiveness, and optimal therapeutic range
9. Guide to anticoagulant therapy, part 2: Oral anticoagulants. AHA Medical/Scientific Statement special report
10. Risk factors for intracranial hemorrhage in outpatients taking warfarin
11. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves
12. Trial of different intensities of anticoagulation in patients with prosthetic heart valves